Friday 6 November 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.

Revenue: +21.8%
EPS: −80.6%
Free cash flow: +6.78%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

45.66 1.12 +2.51%

Follow ALKS

Alert me

Market cap: $7.5B
P/E: 0.0×
Fwd P/E: −85.9×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	19.03	38.02	130.02	0.00
P/S ratio Full definition →		3.12	3.76	5.25	3.88
P/FCF ratio Full definition →		9.57	26.57	39.30	29.78
P/Operating CF Full definition →		27.10	(35.46)	60.28	72.77
P/B ratio Full definition →		2.53	3.36	4.84	3.65
Price to Tangible BV Full definition →		2.66	0.00	0.00	0.00
EV/Sales Full definition →		2.42	4.40	5.76	4.30
EV/EBITDA Full definition →		12.73	28.20	43.12	34.72
EV/Operating CF Full definition →		6.87	26.84	38.21	31.05
EV/FCF Full definition →		7.43	31.08	43.10	33.03
Quick Ratio Full definition →		3.04	1.53	1.68	1.86
Current Ratio Full definition →		3.55	2.27	2.30	2.42
Net Debt/EBITDA Full definition →		(21.30)	(61.92)	10.63	8.08
Debt/Assets Full definition →		0.00%	35.47%	34.22%	33.77%
Debt/Equity Full definition →		0.00	0.86	0.83	0.80
Asset Turnover Full definition →		0.65	0.49	0.50	0.52
Operating CF/Net income Full definition →		3.45	2.49	289.79	5.74
Capex/Depreciation Full definition →		0.28	(0.13)	(0.13)	(0.06)
Interest Coverage Full definition →		—	(2.31)	0.71	1.31
Research and Development Expense of Revenue Full definition →		24.19%	26.30%	22.77%	25.23%
Selling, General and Administrative Expense of Revenue Full definition →		48.68%	67.34%	43.88%	43.43%
Intangible Assets out of Total Assets Full definition →		0.03	0.56	0.54	0.53
Share Based Compensation of Revenue Full definition →		6.83%	9.25%	6.28%	5.57%
Graham Net Nets Full definition →		0.27	(0.20)	(0.12)	(0.15)
Graham Number Full definition →		19.11	14.85	9.91	0.00
Earnings Yield Full definition →		5.25%	2.63%	0.77%	0.00%
Free Cash Flow Yield Full definition →		10.45%	3.76%	2.54%	3.36%
Revenue per Share Full definition →		2.33	2.36	2.97	2.86
Operating CF per Share Full definition →		1.03	(1.00)	0.87	0.56
Capex per Share Full definition →		0.01	(0.02)	(0.05)	(0.02)
Free Cash Flow per Share Full definition →		1.04	(1.02)	0.82	0.54
Cash per Share Full definition →		8.01	3.08	3.93	4.50
Shareholders Equity per Share Full definition →		11.05	10.54	10.83	11.11
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		11.05	10.54	10.83	11.11
Free Cash Flow Full definition →		171.14	(169.82)	137.04	90.08
Working Capital Full definition →		1,385.72	759.15	860.82	928.81
Capital Expenditures Full definition →		1.07	(4.08)	(8.15)	(3.40)
Net Current Asset Value Full definition →		1,261.46	(1,147.90)	(1,061.67)	(990.06)
EV/EBIT Full definition →		14.09	35.83	81.86	117.51
Capex to Sales Full definition →		0.00	0.01	0.02	0.01
Price to Operating Income Full definition →		18.15	30.63	74.64	105.95
Other line items
Average Receivables Full definition →		359.28	363.17	405.69	406.74
Average Payables Full definition →		237.45	239.31	289.11	254.71
Average Inventory Full definition →		189.76	260.07	245.44	226.05
Average Assets Full definition →		2,271.28	3,170.03	3,322.97	3,382.52
Average Common Equity Full definition →		1,642.14	1,631.56	1,716.57	1,799.08

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly